November 9, 2009
TRACON Pharmaceuticals Announces Upcoming Presentation of Clinical Data on TRC102, a Selective Inhibitor of DNA Base Excision Repair and Chemotherapy Resistance
About Us Product Pipeline Partnering News and Events Contact Us
Site Map Home

Site Map

Home

About Us
Company Overview
Management Team
Board of Directors
Careers

Product Pipeline
Pipeline Overview

Partnering
Partnering Overview

Investor Information
Investment Overview
Press Releases
Corporate Fact Sheet

News and Events
Press Releases
Tracon in The News
Event Calendar
Company Updates Signup

Contact Us
Digital Endeavor